Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
---|
08/23/2006 | EP1345907B1 7-heterocyclyl quinoline and thieno 2,3-b|pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
08/23/2006 | EP1332144B1 Indole derivatives as pde5-inhibitors |
08/23/2006 | EP1329451B1 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
08/23/2006 | EP1278747B1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
08/23/2006 | EP1278716B1 Trans-n-¬4-(4-hydroxyphenyl)cyclohexyl|-3-phenylpropionamide as subtype selective nmda receptor antagonist |
08/23/2006 | EP1261330B1 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and in lower animals |
08/23/2006 | EP1146870B1 Antioxidant compositions for companion animals |
08/23/2006 | CN1820777A Process for preparing micrometer sugared shentiandiyinluyi, kidney invigorating and fatigue reducing wine |
08/23/2006 | CN1820756A Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
08/23/2006 | CN1820634A Instant Job's tears seed and its preparing method |
08/23/2006 | CN1271070C Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine A2a receptor and their use as medicaments |
08/23/2006 | CN1271054C Urea compounds having muscarinic receptor antagonist activity |
08/23/2006 | CN1270763C Preparation method for removing blood stasis keeping kidney essence and its use |
08/23/2006 | CN1270760C Traditional Chinese medicine composition for treating nephritis and uraemia |
08/23/2006 | CN1270750C Medicine for treating chronic nephritis, and its prepn. method |
08/23/2006 | CN1270732C Diuretic stone-excreting medicine and its prepn. |
08/23/2006 | CN1270708C Medicinal composition for treating interstitial cystitis |
08/22/2006 | US7094896 Diaminothiazoles having antiproliferative activity |
08/22/2006 | US7094877 Protein for use in treatment of inflammation, nervous system, pain, arthritic and skin disorders |
08/22/2006 | US7094802 PKB-3564 substance with neovascularization inhibitory activity |
08/22/2006 | US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis |
08/22/2006 | US7094797 Organ fibrosis inhibitor |
08/22/2006 | US7094781 Sulfamides and their use as endothelin receptor antagonists |
08/22/2006 | US7094779 2-(3-indolylmethyl)-1-benzoyl-4-oxime-piperazine derivatives, e.g., 1-{(2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(1H-indol-3-ylmethyl)-piperazin-4-yl}-2-propanone O-[2-(dimethylamino)-ethyl]oxime, used for treatment of CNS disorders. |
08/22/2006 | US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction |
08/22/2006 | US7094549 mass spectroscopy; medical diagnosis/prognosis; kits |
08/17/2006 | WO2006085692A1 Crystal of 4(3h)-quinazolinone derivative |
08/17/2006 | WO2006085607A1 Plant component-containing emulsion preparation and method for producing the same |
08/17/2006 | WO2006085497A1 Tablet disintegrating in the oral cavity |
08/17/2006 | WO2006085079A2 Pharmaceutically active phosphate binders, their manufacture, compositions containing them and their use |
08/17/2006 | WO2006084322A1 Treatment method for modifying tissue passive electrical conductance |
08/17/2006 | WO2003053346A3 Systems and methods for treating patients with processed lipoaspirate cells |
08/17/2006 | US20060183931 Multi-substituted selective androgen receptor modulators and methods of use thereof |
08/17/2006 | US20060183805 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
08/17/2006 | US20060183770 Sulfonamide derivative having isoxazole ring |
08/17/2006 | US20060183757 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
08/17/2006 | US20060183753 Use of substituted 2,5-diamidoindoles for the treatment of urological diseases |
08/17/2006 | US20060183734 (4-cyclohexyl-phenyl)-(4H, 10H-3a,5,9-triaza-benzo[f]azulen-9-yl)-methanone; antidiuretic, anticoagulant, diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, delay of urination, or bleeding |
08/17/2006 | US20060182814 Biochemically balanced peritoneal dialysis solutions |
08/17/2006 | CA2597541A1 Crystal of 4(3h)-quinazolinone derivative |
08/17/2006 | CA2597124A1 Pharmaceutically active compounds, their manufacture, compositions containing them and their use |
08/16/2006 | EP1690857A1 Modified-protein formation inhibitor |
08/16/2006 | EP1690536A2 Use of r-(+)-2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxy-methyl-phenylisobutyric acid ester hydrogenfumarate for the treatment of urinary incontinence and other spasmogenic disorders |
08/16/2006 | EP1689447A2 Gene transfer for regulating smooth muscle tone |
08/16/2006 | EP1689420A1 Use of g-csf for treating ischemia |
08/16/2006 | EP1689419A1 Pharmaceutical compositions including low dosages of desmopressin |
08/16/2006 | EP1509241B1 Novel uses of cephaibols |
08/16/2006 | EP1368320B1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof |
08/16/2006 | EP1220670B1 Use of l-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use |
08/16/2006 | EP1183020B1 (3-trihalomethylphenoxy) (4-halophenyl) for the treatment of insulin resistance and type 2 diabetes |
08/16/2006 | EP1165490B1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
08/16/2006 | EP1137410B1 Novel 4-dedimethyl aminotetracycline derivatives |
08/16/2006 | EP1117682B1 Chi-Conotoxin Peptides as INhibitors of Neuronal Amine Transporters |
08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
08/16/2006 | EP0880523B1 Pyrazolopyrimidines as crf receptor antagonists |
08/16/2006 | CN1820078A Recombinant mutants of rhabdovirus and methods of use thereof |
08/16/2006 | CN1820001A Substituted heterocyclic diarylamine analogues |
08/16/2006 | CN1819845A Medicinal composition containing NF-kappa B decoy for treating and preventing respiratory diseases and method of using the same |
08/16/2006 | CN1819776A Process for producing liquid formulation containing raw yeast and liquid formulation |
08/16/2006 | CN1817883A New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound |
08/16/2006 | CN1817363A Medicine for treating various diseases |
08/16/2006 | CN1817157A Preparation of kidney-tonifying and fatigue-dispelling bean milk with micro-meter Hairy Antler safflower |
08/16/2006 | CN1817156A Preparation of kidney-tonifying and fatigue-dispelling bean-milk tablet with micro-meter Hairy Antler safflower |
08/16/2006 | CN1269963C Cardiac atrium peptide gene transfecting cell microcapsule |
08/16/2006 | CN1269942C Hops extracts, method for prodn. and use |
08/16/2006 | CN1269940C Method for extracting lipid from marine and aquatic animal tissues |
08/16/2006 | CN1269820C Novel pyrrole derivatives as pharmaceutical agents |
08/16/2006 | CN1269818C Lactam compounds and medicinal use thereof |
08/16/2006 | CN1269814C Process and intermediates for pyridazinone antidiabetic agents |
08/16/2006 | CN1269807C Aryl substituted piperazine for curing benign prostatauxe |
08/16/2006 | CN1269804C Metalloproteinase inhibitors |
08/16/2006 | CN1269520C Medicine for treating human lithic disease |
08/16/2006 | CN1269514C Kidney supplementing life prolonging preparation and its making method |
08/16/2006 | CN1269509C Medicine for treating chronic nephritis, and its prepn. method |
08/16/2006 | CN1269508C Preparation method of medicine for treating chronic renal failure |
08/15/2006 | USRE39239 Methods for treating early morning pathologies |
08/15/2006 | US7091352 Antiinflammatory agents; analgesics; antiarthritic agents |
08/15/2006 | US7091323 Human TIMP-1 antibodies |
08/15/2006 | US7091234 Thio-oxindole derivatives |
08/15/2006 | US7091232 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
08/15/2006 | US7091227 Serine/threonine and tyrosine kinases inhibitors |
08/15/2006 | US7091220 Substituted indole Mannich bases |
08/15/2006 | US7091204 Sulfonamides |
08/15/2006 | US7091203 Imidazo[1,3,5]triazinones and their use |
08/15/2006 | US7091200 adrenoceptor or G-protein coupled receptors inhibitors such as 3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-6,7-dimethoxy-2H-benzo[1,2,4]-thiadiazine-1,1-dioxide and carriers, used for prophylaxis of urogenital disorders, or as analgesics |
08/15/2006 | US7091195 Derived from plants; for preventing or inhibiting tumor growth |
08/15/2006 | CA2215476C Arginine analogues having nitric oxide synthase inhibitor activity |
08/10/2006 | WO2006083005A1 Fused pyrimidine derivative and used thereof |
08/10/2006 | WO2006082975A1 Optically active tetrahydronaphthalene derivative |
08/10/2006 | WO2006082952A1 Amide compound |
08/10/2006 | WO2006082888A1 Percutaneous absorption preparation |
08/10/2006 | WO2006082872A1 1-(piperidin-4-yl)-1h-indole derivative |
08/10/2006 | WO2006082643A1 Preventive, relieving or therapeutic composition for diabetes mellitus and/or diabetic nephropathy |
08/10/2006 | WO2006081994A2 Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostate hyperplasia and/or prostate carcinoma |
08/10/2006 | WO2006061791A3 Novel diazabicyclononene derivative |
08/10/2006 | WO2006024492A3 Medical implant provided with inhibitors of atp synthesis |
08/10/2006 | WO2006024490A3 Methods and compositions for the treatment of cell proliferation |
08/10/2006 | WO2006024489A3 Methods and compositions for the treatment of cell proliferation |
08/10/2006 | WO2006012310A3 Carbazole derivatives for treating polycystic kidney disease |
08/10/2006 | US20060178375 2-(1-Cyclopentylpiperidin-4-yloxy)-5-(4-cyanophenyl)pyrimidine, for example; exhibits histamine receptor H3 antagonist or inverse agonist activity and is useful for the treatment and/or prevention of obesity, diabetes, hormonal secretion abnormality, sleep disorders |